Persistent genital arousal disorder following selective serotonin reuptake inhibitor cessation.
Foundation Programme West Midlands Deanery United Kingdom frederico.magalhaes@nhs.net South Staffordshire and Shropshire Foundation Trust St George's Hospital Stafford, United Kingdom.
Frederico José Coelho
FJ
de Magalhães
Manoj Therayil
MT
Kumar
D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy*
D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors